Streamex

Streamex FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Streamex (STEX) as of Oct 20, 2026 is 2.26 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 46.06 % — a change of -95.10% (lower).

FCF Conversion

2.26 %

YoY

-95.10%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Streamex is 2025 2.26 % . FCF Conversion Rate (FCF/EBITDA) of Streamex was 2024 46.06 % . It decreases by -95.10% lower compared to the previous year.

The Streamex FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
58.24 USD
Jan 1, 2019
46.28 USD
Jan 1, 2020
51.11 USD
Jan 1, 2021
84.41 USD
Jan 1, 2022
80.86 USD
Jan 1, 2023
60.26 USD
Jan 1, 2024
46.06 USD
Jan 1, 2025
2.26 USD
The Streamex FCF Conversion history
YEARFCF ConversionYoY
2.26 %-95.10%
46.06 %-23.56%
60.26 %-25.48%
80.86 %-4.21%
84.41 %+65.16%
51.11 %+10.44%
46.28 %-20.54%
58.24 %-0.20%
58.36 %+33.24%
43.80 %-5.31%
46.26 %+102.83%
22.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Streamex Stock analysis

What does Streamex do? Streamex Corp, with ticker STEX and ISIN US09073N3008, is a U.S.-based health care company headquartered in Westport. The company has six employees and went public on September 22, 2014. Streamex Corp's website is https://biosigtech.com/. The company operates within the health care sector, focusing on medical technology. It develops a proprietary biomedical signal processing platform aimed at enhancing signal fidelity and analyzing electrocardiographic and intra-cardiac signals. The platform is designed to extract information from physiologic signals, particularly for use during electrophysiology studies and cardiac catheter ablation procedures. The company's technology is intended to provide intracardiac signal information to electrophysiologists, supporting procedures for conditions such as atrial fibrillation and ventricular tachycardia. Streamex Corp's website redirects to biosigtech.com, which appears to be associated with BioSig Technologies, Inc., a company described in a source as having a different employee count and additional product details. However, based solely on the provided facts, Streamex Corp is a small company with six employees, operating in the health care industry with a focus on signal processing technology for cardiac procedures. Streamex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Streamex stock

FCF Conversion Rate (FCF/EBITDA) of Streamex is 2.26 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Streamex changed from 46.06 % to 2.26 %, representing a -95.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Streamex since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Streamex with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Streamex

All Key Metrics — Streamex